15 Low Profile Dividend Champions to Buy
Companies known as Dividend Aristocrats belong to the S&P Index and have raised their dividend payments every year for a minimum of 25 years.
West Pharmaceutical Services Inc (WST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Solstein Capital Nadine Terman And Jc Torres | 34 | $7,612 | 0% | |
| 2. | Sivik Global Healthcare Krishen Sud | 12,500 | $2,799 | 1.51% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $105.14 | 54 | 66,251 | 2019-02-28 | Filing | ||
| $110.55 | 57 | 66,197 | 2018-07-31 | Filing | ||
| $93.94 | 335 | 66,475 | 2017-10-17 | Filing | ||
| $88.89 | 275 | 56,540 | 2018-05-15 | Filing | ||
| $84.53 | 332 | 51,831 | 2016-12-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $310.40 | 225 | Officer | 1,253 | 2024-10-29 | Filing | |
| $310.40 | 478 | Officer | 1,478 | 2024-10-29 | Filing | |
| $300.00 | 500 | Officer | 1,478 | 2024-08-19 | Filing | |
| $300.00 | 529 | Officer | 1,978 | 2024-08-19 | Filing | |
| $365.92 | 617 | Director | 43,565 | 2024-05-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 441,357 | $98,811,005 | 6.46% | |
| 2. | 408,406 | $91,433,998 | 1.47% | |
| 3. | 253,252 | $56,698,094 | 0.42% | |
| 4. | 236,797 | $53,013,989 | 0.05% | |
| 5. | 234,807 | $52,568,591 | 0.09% |
News See All
Why These 15 Large-Cap Stocks Are Plunging So Far In 2025
The big and large-cap stocks have spearheaded the rally in the past two years, but Wall Street’s expectations have gotten ahead of many of their fundamentals.
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2024 Earnings Call Transcript February 13, 2025West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceutical Services (WST) Bounced Back in Q4
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. For the second consecutive year, U.S.
Should You Sell Your Holdings in West Pharmaceutical Services (WST)?
ClearBridge Investments, an investment management company, released its “ClearBridge Mid Cap Growth Strategy” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
UBS' Bottom Quant Stocks In AI, IT, Healthcare & Others: 29 Stocks In All Sectors
With November 2024 having settled in and the US presidential election in its final stages, investors are also digesting the results of the latest earnings season.
West Pharmaceutical Services (WST) Fell Due to Lower-Than-Expected Results and Reduced Guidance
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript
West Pharmaceutical Services, Inc. (NYSE:WST) Q3 2024 Earnings Call Transcript October 24, 2024West Pharmaceutical Services, Inc. beats earnings expectations.
West Pharmaceuticals (WST) Fell Due to Industry Headwinds
Conestoga Capital Advisors, an asset management company, released its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
